Today in News History
On July 12, several notable moments in the history of News stand out. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1920, The Soviet-Lithuanian Peace Treaty is signed, by which Soviet Russia recognizes the independence of Lithuania. In 1923, James E. Gunn, American science fiction author (died 2020) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1961, Indian city Pune floods due to failure of the Khadakwasla and Panshet dams, killing at least two thousand people. In 1997, Malala Yousafzai, Pakistani-English activist, Nobel Prize laureate was born. In 2000, Charles Merritt, Canadian colonel and politician, Victoria Cross recipient (born 1908) passed away. In 2001, Space Shuttle program: Space Shuttle Atlantis is launched on mission STS-104, carrying the Quest Joint Airlock to the International Space Station. In 2006, The 2006 Lebanon War begins. In 2012, Syrian Civil War: Government forces target the homes of rebels and activists in Tremseh and kill anywhere between 68 and 150 people. Together, these milestones provide historical context for today's news news and ongoing narratives.
Tumors found to rewire immune cells, may lead to new cancer treatments
Reprogrammed macrophages activated genes that promote the formation of blood vessels within tumors.
Narrative Intelligence Brief
This article was published by Jewish News Syndicate, a source frequently categorized with a center bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Jewish News Syndicate, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Jewish News Syndicate
July 12, 2026
Israeli research offers new hope for overcoming one of the deadliest brain cancers
July 12, 2026
IDF strikes Hezbollah terrorists transferring weapons in Southern Lebanon
July 12, 2026
IDF declassifies first operational order of Second Lebanon War
July 12, 2026
Israeli gov't votes to extend nationwide emergency measures through July 28
July 12, 2026
Technical glitch triggers false missile warning in central Israel
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"lindsey graham"
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 0%
Center 83%
Right 0%
Middle East News 247
· Jun 23, 2026
Mayo Clinic researchers find new hope for toughest myeloma through off-the-shelf immunotherapy
A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma — one of the most aggressive and treatment-resistant forms of the disease. “We are seeing powerful responses in a disease that historically has resisted every therapy,” [] The post Mayo Clinic researchers find new hope for toughest myeloma through off-the-shelf immunotherapy appeared first on Middle East News 247.
Global News
· Jul 3, 2026
University of Calgary developing new immunotherapy cancer treatment
The immunotherapy offers an alternative treatment when chemotherapy, radiation and surgery are no longer effective. The next phase of the trial is recruiting patients.
Science
· Jul 9, 2026
The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity | Science
The cancer-immunity cycle requires cross-presenting type I conventional dendritic cells (cDC1s) that induce T cell–mediated immunity, but therapeutic strategies for enhancing intratumoral cDC1 function are currently inadequate. We found the epigenetic ...
The Eastern Herald
· Jul 2, 2026
An Immune Cell Meant to Fight Cancer Gets Reprogrammed by Tumors to Help Them Instead
Tel Aviv University researchers found that macrophages, the immune cells that clear dead cancer cells, get reprogrammed to stimulate tumor blood vessel growth instead of fighting cancer. The Effero-seq technology used to track this process in real time may point toward a new class of therapeutic targets.
Science Daily
· Jun 25, 2026
FDA-approved drug may finally help immunotherapy defeat rare liver cancer
Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples.
Medical Daily
· Jul 11, 2026
The Most Popular Gym Supplement May Also Help Immune Cells Fight Cancer, UCLA Study Finds
A UCLA study in iScience found creatine may fuel dendritic immune cells that activate cancer-fighting T cells, slowing tumor growth in mice and boosting human immune cells in lab tests.
Topics:
Related coverage for "Tumors found to rewire immune cells, may lead to new cancer treatments": Middle East News 247 — Mayo Clinic researchers find new hope for toughest myeloma through off-the-shelf immunotherapy. Global News — University of Calgary developing new immunotherapy cancer treatment. Science — The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity | Science. The Eastern Herald — An Immune Cell Meant to Fight Cancer Gets Reprogrammed by Tumors to Help Them Instead. Science Daily — FDA-approved drug may finally help immunotherapy defeat rare liver cancer. Medical Daily — The Most Popular Gym Supplement May Also Help Immune Cells Fight Cancer, UCLA Study Finds